Singleron Biotechnologies is Decision/Risk Analysis in China that focus on single cell business. Founded in 2018. They cover business area such as developer, single cell multi-omics platform, clinical diagnosis, health management, drug development, single-cell multi-omic analysis technology, a series, molecular diagnostic product, automate equipment.
2018
( 6 years old in 2024 )
Single Cell
-
Floors 4-5, Building 06, Accelerator Phase II
No. 11 Yaogu Avenue, Jiangbei New District
Nanjing, Jiangsu
China
Private
developersingle cell multi-omics platformclinical diagnosishealth managementdrug developmentsingle-cell multi-omic analysis technologya seriesmolecular diagnostic productautomate equipment
* We use standard office opening hours in near Singleron Biotechnologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Singleron Biotechnologies is Decision/Risk Analysis business from China that founded in 2018 (6 years old in 2024), Singleron Biotechnologies business is focusing on Single Cell.
Singleron Biotechnologies headquarter office and corporate office address is located in Floors 4-5, Building 06, Accelerator Phase II No. 11 Yaogu Avenue, Jiangbei New District Nanjing, Jiangsu China.
Singleron Biotechnologies was founded in China.
In 2024, Singleron Biotechnologies is currently focus on single cell sector.
Above is snippet of Google Trends for "single cell" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Singleron Biotechnologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
